Article
In vitro activity of ceftazidime-avibactam, imipenem-relebactam, aztreonam-avibactam, and comparators toward carbapenem-resistant and hypervirulent Klebsiella pneumoniae isolates
20 Nov 2023
Abstract excerpt
ABSTRACT Carbapenem-resistant and hypervirulent Klebsiella pneumoniae (CR-hvKP) strains are increasingly reported, posing a significant threat to public health. Therefore, effective antimicrobial therapy is urgently needed. This study aimed to analyze the in vitro activity of ceftazidime-avibactam (CZA), imipenem-relebactam (IMR), and aztreonam-avibactam (AZA) toward CR-hvKP and carbapenem-resistant Klebsiella...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
